SPHINX-Based Combination Therapy as a Potential Novel Treatment Strategy for Acute Myeloid Leukaemia

Conclusion: We suggest that specific types of leukaemia may present an opportunity for the development of SRPK1-targeted therapies to be used in combination with established chemotherapeutic drugs.PMID:36895328 | PMC:PMC9988938 | DOI:10.3389/bjbs.2023.11041
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Authors: Source Type: research